A queuing model to address waiting time inconsistency in solid-organ transplantation
نویسندگان
چکیده
منابع مشابه
Introduction to Solid Organ Transplantation
Organ transplantation has been the subject of ancient myths dating back to the twelfth century. The modern era of transplantation began in the early 1900s with the development of surgical techniques for constructing vascular anastomoses [ 1 ] leading to successful kidney transplantation in dogs in 1902 [ 2 ]. The fi rst series of human kidney transplants were performed in the Ukraine beginning ...
متن کاملCoccidioidomycosis in solid organ transplantation.
Coccidioidomycosis is an endemic fungal infection of the southwestern United States. Normally a self-limited infection in healthy hosts, coccidioidomycosis can become a serious complication in patients who have had solid organ transplantation. Among patients whose solid organ transplantation was complicated by coccidioidomycosis, the infection has a variety of clinical presentations. Disseminat...
متن کاملMacrophages in solid organ transplantation
Macrophages are highly plastic hematopoietic cells with diversified functions related to their anatomic location and differentiation states. A number of recent studies have examined the role of macrophages in solid organ transplantation. These studies show that macrophages can induce allograft injury but, conversely, can also promote tissue repair in ischemia-reperfusion injury and acute reject...
متن کاملTuberculosis in Solid Organ Transplantation
Active tuberculosis (TB) is one of the major opportunistic infections that may occur in solid organ transplant recipients. Diagnosis and treatment of latent and active TB are challenging in this population due to lack of randomized clinical trials. In this review, we discuss the clinical manifestations of TB, diagnosis of latent TB and treatment of both latent and active TB.
متن کاملAspergillosis in solid organ transplantation.
Invasive aspergillosis (IA) occurs in 1–15% of the solid organ transplant (SOT) recipients. Mortality rate in transplant recipients with IA historically has ranged from 65% to 92% (1–4). However, currently reported mortality rate in IA among SOT recipients is 22% (5). An estimated 9.3– 16.9% of all deaths in transplant recipients in the first year have been considered attributable to IA (6). Al...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Operations Research for Health Care
سال: 2014
ISSN: 2211-6923
DOI: 10.1016/j.orhc.2014.01.001